How much is Pharvaris worth in 2026?

Pharvaris has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Pharvaris raised?

Pharvaris has raised N/A in total funding across 1 funding rounds.

Pharvaris

Drug Discovery

Pharvaris valuation and funding history | Last updated: November 5, 2020 | 1 funding rounds

Current Valuation

N/A

As of November 5, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$80.0M

Last Funding

Nov 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 5, 2020	Later Stage VC (Series C)	$80.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Pharvaris is currently valued at N/A as of November 5, 2020.

Track Pharvaris Valuation Updates

Get notified when Pharvaris raises new funding or valuation changes

Explore More Data

Detailed analysis for Pharvaris

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Pharvaris's valuation history, funding rounds, and growth metrics.

No credit card required

What is Pharvaris Worth in 2026?

Pharvaris is a leading private company in the Drug Discovery sector. Track Pharvaris's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Pharvaris Valuation is Determined

Private company valuations like Pharvaris's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.